Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer

NCT02620800 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Pancreas Adenocarcinoma

Interventions

DRUG: 5FU
DRUG: nab-paclitaxel
DRUG: bevacizumab
DRUG: calcium leucovorin
DRUG: oxaliplatin

Sponsor

Celgene